Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients

D. Pickar, Alan Breier, J. Kelsoe

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Despite the limitations of the dopamine hypothesis, compelling evidence remains that implicates dysfunction of CNS dopamine systems in the pathophysiology of schizophrenia. The longitudinal measurement of levels of plasma HVA has proved a useful tool in studying neuroleptic effects and has highlighted time-dependent effects as a potentially important facet of the mechanism of antipsychotic action of these drugs. Despite the good clinical correlates of plasma HVA levels, caution is needed in interpreting plasma levels of HVA with regard to CNS dopamine activity. The peripheral nervous system significantly contributes to levels of HVA that circulate in plasma. This issue is underscored by the fact that CSF HVA shows different neuroleptic response patterns than that seen in plasma. The administration of a peripherally acting MAO inhibitor to enhance the CNS 'signal' in circulating levels of HVA does not resolve the 'problem' of different CSF-plasma HVA neuroleptic response patterns. The possibility that mesocortical dopamine activity is reflected by CSF HVA is suggested by indirect evidence from clinical and preclinical studies. Future studies in which attempts are made at using both plasma and CSF HVA to enhance neurochemical and clinical correlates may help to advance our understanding of the contributions of specific CNS dopamine systems to schizophrenia.

Original languageEnglish (US)
Pages (from-to)339-346
Number of pages8
JournalAnnals of the New York Academy of Sciences
Volume537
StatePublished - 1988
Externally publishedYes

Fingerprint

Homovanillic Acid
Plasmas
Dopamine
Antipsychotic Agents
Schizophrenia
Monoamine Oxidase Inhibitors
Peripheral Nervous System
Neurology
Plasma
Central Nervous System
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Plasma homovanillic acid as an index of central dopaminergic activity : studies in schizophrenic patients. / Pickar, D.; Breier, Alan; Kelsoe, J.

In: Annals of the New York Academy of Sciences, Vol. 537, 1988, p. 339-346.

Research output: Contribution to journalArticle

@article{395b30e13bf44d36a18d68077a6a85a0,
title = "Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients",
abstract = "Despite the limitations of the dopamine hypothesis, compelling evidence remains that implicates dysfunction of CNS dopamine systems in the pathophysiology of schizophrenia. The longitudinal measurement of levels of plasma HVA has proved a useful tool in studying neuroleptic effects and has highlighted time-dependent effects as a potentially important facet of the mechanism of antipsychotic action of these drugs. Despite the good clinical correlates of plasma HVA levels, caution is needed in interpreting plasma levels of HVA with regard to CNS dopamine activity. The peripheral nervous system significantly contributes to levels of HVA that circulate in plasma. This issue is underscored by the fact that CSF HVA shows different neuroleptic response patterns than that seen in plasma. The administration of a peripherally acting MAO inhibitor to enhance the CNS 'signal' in circulating levels of HVA does not resolve the 'problem' of different CSF-plasma HVA neuroleptic response patterns. The possibility that mesocortical dopamine activity is reflected by CSF HVA is suggested by indirect evidence from clinical and preclinical studies. Future studies in which attempts are made at using both plasma and CSF HVA to enhance neurochemical and clinical correlates may help to advance our understanding of the contributions of specific CNS dopamine systems to schizophrenia.",
author = "D. Pickar and Alan Breier and J. Kelsoe",
year = "1988",
language = "English (US)",
volume = "537",
pages = "339--346",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Plasma homovanillic acid as an index of central dopaminergic activity

T2 - studies in schizophrenic patients

AU - Pickar, D.

AU - Breier, Alan

AU - Kelsoe, J.

PY - 1988

Y1 - 1988

N2 - Despite the limitations of the dopamine hypothesis, compelling evidence remains that implicates dysfunction of CNS dopamine systems in the pathophysiology of schizophrenia. The longitudinal measurement of levels of plasma HVA has proved a useful tool in studying neuroleptic effects and has highlighted time-dependent effects as a potentially important facet of the mechanism of antipsychotic action of these drugs. Despite the good clinical correlates of plasma HVA levels, caution is needed in interpreting plasma levels of HVA with regard to CNS dopamine activity. The peripheral nervous system significantly contributes to levels of HVA that circulate in plasma. This issue is underscored by the fact that CSF HVA shows different neuroleptic response patterns than that seen in plasma. The administration of a peripherally acting MAO inhibitor to enhance the CNS 'signal' in circulating levels of HVA does not resolve the 'problem' of different CSF-plasma HVA neuroleptic response patterns. The possibility that mesocortical dopamine activity is reflected by CSF HVA is suggested by indirect evidence from clinical and preclinical studies. Future studies in which attempts are made at using both plasma and CSF HVA to enhance neurochemical and clinical correlates may help to advance our understanding of the contributions of specific CNS dopamine systems to schizophrenia.

AB - Despite the limitations of the dopamine hypothesis, compelling evidence remains that implicates dysfunction of CNS dopamine systems in the pathophysiology of schizophrenia. The longitudinal measurement of levels of plasma HVA has proved a useful tool in studying neuroleptic effects and has highlighted time-dependent effects as a potentially important facet of the mechanism of antipsychotic action of these drugs. Despite the good clinical correlates of plasma HVA levels, caution is needed in interpreting plasma levels of HVA with regard to CNS dopamine activity. The peripheral nervous system significantly contributes to levels of HVA that circulate in plasma. This issue is underscored by the fact that CSF HVA shows different neuroleptic response patterns than that seen in plasma. The administration of a peripherally acting MAO inhibitor to enhance the CNS 'signal' in circulating levels of HVA does not resolve the 'problem' of different CSF-plasma HVA neuroleptic response patterns. The possibility that mesocortical dopamine activity is reflected by CSF HVA is suggested by indirect evidence from clinical and preclinical studies. Future studies in which attempts are made at using both plasma and CSF HVA to enhance neurochemical and clinical correlates may help to advance our understanding of the contributions of specific CNS dopamine systems to schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0024206565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024206565&partnerID=8YFLogxK

M3 - Article

C2 - 2904783

AN - SCOPUS:0024206565

VL - 537

SP - 339

EP - 346

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -